Base Year: 2018
Estimated Year: 2019
Forecast Period: 2019 to 2026
Pharma is the industry engaged in researching, developing, manufacturing and distributing drugs including prescription drugs and OTC drugs for human or veterinary use. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may only be sold to consumers possessing a valid prescription.
Market Insights
The study projects that the Pharma and OTC market will register a xxxx% CAGR in terms of revenue, which is expected to reach USD xxxx million in 2026 from USD xxxx million in 2019.
Certain factors affecting the market expansion, such as the increased inclination preference towards self-medication for treatment of minor health conditions, innovative technologies in the dosage forms of the drugs, as well as the low prices of the OTC drugs. Further, the high penetration of the drugs in the emerging economies and more favorable regulatory framework are propelling the trend as well.
One thing needs to point out is the diversity of distribution channels and new emerging markets will pose a lucrative opportunity for market growth, coving supermarkets, retail markets, etc.
Geographically, the global Pharma and OTC market is dominated by North America areas, since the changing preference from Rx to OTC drugs attached by pharmaceutical manufacturers in the region. However, the most worthy-of-attention regions in terms of growth rate during the forecast period are Latin America and Southeast Asia, this is due to the rapid population numbers, the growing middle-class consumers, along with the improving life standard in the region.
Get FREE Sample of Pharma and OTC Market Report at:
Competitive Outlook
The major global Pharma and OTC market competitors include Johnson & Johnson, Novartis International AG, Bayer, Sanofi S.A., Pfizer, GlaxoSmithKline PLC, Boehringer Ingelheim, PGT Healthcare, Takeda, Endo, Abbott, Daiichi-Sankyo, Teva Pharmaceutical, etc.
Type Outlook
• Prevent Respiratory Infections
• Antibacterial
• Analgesia
• Treatment of Skin Diseases
• Other
Application Outlook
• Hospital
• Clinic
• Drug Store
Purchase a copy of Pharma and OTC report at:
Regions Covered in the Report:
North America
• United States
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Italy
• Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
• Spain
• Belgium
• Poland
• Russia
• Turkey
• Others
Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia and New Zealand
• ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)
Latin America, Middle East & Africa
• GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
• Brazil
• Nigeria
• South Africa
• Argentina
• Others
Ask for a discount at:
The research report provides in-depth analysis on:
• The estimation of the growth rate, market size and share of the Pharma and OTC Market throughout the forecast period.
• The assessments for the regional market layout characteristics in the world.
• The SWOT of the Pharma and OTC Market.
• Leading manufacturers' profiles, product features, business features, target customer features.
• Significant trends for the growth prospects of the Pharma and OTC Market by 2026.
• The report tracks detailed information about merges, innovations, policies and recent developments in the industry.
Contact:
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Phone: + 1 (347) 467 7721
Email: info@globalmarketmonitor.com
Web Site: https://www.globalmarketmonitor.com
We provide more professional and intelligent market reports to complement your business decisions.
Chinese